glp-1 and dual glp-1/gip receptor agonists GIPR/GLP-1R agonist therapies for diabetes weight loss—chemistry, physiology, and clinical applications Understanding GLP-1 receptor agonists and

Many people find fast, significant and sustainable weight loss following the Allurion Programme, meaning for them it is an ideal first-line treatment and many would not consider taking a medication at all

Cardiovascular protection: Some GLP-1 medications have been shown to reduce the risk of major cardiovascular events such as heart attack, stroke, and cardiovascular death in people with type 2 diabetes, particularly those with existing cardiovascular disease or multiple risk factors

Maturity-onset diabetes of the young: what do clinicians need to know

However, concerns about their potential link to cancers, such as thyroid cancer, have surfaced

In both the studies, there was a significant increase in heart rate or pulse rate

Higher costs nationwide Blue Cross Blue Shield associations in Michigan, Massachusetts, New York, Arkansas, Rhode Island and Vermont were all in the red last year, too